BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23374508)

  • 1. Importance of uncharged polar residues and proline in the proximal two-thirds (Pro107-Ser128) of the highly conserved region of mouse ileal Na+-dependent bile acid transporter, Slc10a2, in transport activity and cellular expression.
    Saeki T; Sato K; Ito S; Ikeda K; Kanamoto R
    BMC Physiol; 2013 Feb; 13():4. PubMed ID: 23374508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of uncharged polar residues and proline in the distal one-third (Thr130-Pro142) of the highly conserved region of mouse Slc10a2.
    Saeki T; Mizushima S; Ueda K; Iwami K; Kanamoto R
    Biosci Biotechnol Biochem; 2009 Jul; 73(7):1535-40. PubMed ID: 19584562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Ala substitution for conserved Cys residues in mouse ileal and hepatic Na+-dependent bile acid transporters.
    Saeki T; Munetaka Y; Ueda K; Iwami K; Kanamoto R
    Biosci Biotechnol Biochem; 2007 Aug; 71(8):1865-72. PubMed ID: 17690477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane domain II of the human bile acid transporter SLC10A2 coordinates sodium translocation.
    Sabit H; Mallajosyula SS; MacKerell AD; Swaan PW
    J Biol Chem; 2013 Nov; 288(45):32394-32404. PubMed ID: 24045943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2): novel haplotype block including six newly identified variants linked to reduced expression.
    Renner O; Harsch S; Schaeffeler E; Schwab M; Klass DM; Kratzer W; Stange EF
    Hum Genet; 2009 May; 125(4):381-91. PubMed ID: 19184108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipid flippase heterodimer ATP8B1-CDC50A is essential for surface expression of the apical sodium-dependent bile acid transporter (SLC10A2/ASBT) in intestinal Caco-2 cells.
    van der Mark VA; de Waart DR; Ho-Mok KS; Tabbers MM; Voogt HW; Oude Elferink RP; Knisely AS; Paulusma CC
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2378-86. PubMed ID: 25239307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane domain V plays a stabilizing role in the function of human bile acid transporter SLC10A2.
    Moore RH; Chothe P; Swaan PW
    Biochemistry; 2013 Jul; 52(30):5117-24. PubMed ID: 23815591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SLC10 carrier family: transport functions and molecular structure.
    Döring B; Lütteke T; Geyer J; Petzinger E
    Curr Top Membr; 2012; 70():105-68. PubMed ID: 23177985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane helix 1 contributes to substrate translocation and protein stability of bile acid transporter SLC10A2.
    da Silva TC; Hussainzada N; Khantwal CM; Polli JE; Swaan PW
    J Biol Chem; 2011 Aug; 286(31):27322-32. PubMed ID: 21646357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed mutagenesis and use of bile acid-MTS conjugates to probe the role of cysteines in the human apical sodium-dependent bile acid transporter (SLC10A2).
    Banerjee A; Ray A; Chang C; Swaan PW
    Biochemistry; 2005 Jun; 44(24):8908-17. PubMed ID: 15952798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of genetic variants in the apical sodium-dependent bile acid transporter (ASBT; SLC10A2).
    Ho RH; Leake BF; Urquhart BL; Gregor JC; Dawson PA; Kim RB
    J Gastroenterol Hepatol; 2011 Dec; 26(12):1740-8. PubMed ID: 21649730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC10A4 is a protease-activated transporter that transports bile acids.
    Abe T; Kanemitu Y; Nakasone M; Kawahata I; Yamakuni T; Nakajima A; Suzuki N; Nishikawa M; Hishinuma T; Tomioka Y
    J Biochem; 2013 Jul; 154(1):93-101. PubMed ID: 23589386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice.
    Dawson PA; Haywood J; Craddock AL; Wilson M; Tietjen M; Kluckman K; Maeda N; Parks JS
    J Biol Chem; 2003 Sep; 278(36):33920-7. PubMed ID: 12819193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human bile acid transporter ASBT (SLC10A2) forms functional non-covalent homodimers and higher order oligomers.
    Chothe PP; Czuba LC; Moore RH; Swaan PW
    Biochim Biophys Acta Biomembr; 2018 Mar; 1860(3):645-653. PubMed ID: 29198943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter.
    Dawson PA; Hubbert M; Haywood J; Craddock AL; Zerangue N; Christian WV; Ballatori N
    J Biol Chem; 2005 Feb; 280(8):6960-8. PubMed ID: 15563450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topology scanning and putative three-dimensional structure of the extracellular binding domains of the apical sodium-dependent bile acid transporter (SLC10A2).
    Zhang EY; Phelps MA; Banerjee A; Khantwal CM; Chang C; Helsper F; Swaan PW
    Biochemistry; 2004 Sep; 43(36):11380-92. PubMed ID: 15350125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Inhibiting Ileal Apical versus Basolateral Bile Acid Transport on Cholesterol Metabolism and Atherosclerosis in Mice.
    Dawson PA
    Dig Dis; 2015; 33(3):382-7. PubMed ID: 26045273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of substrate specificity for the bile salt transporter ASBT (SLC10A2).
    Lionarons DA; Boyer JL; Cai SY
    J Lipid Res; 2012 Aug; 53(8):1535-42. PubMed ID: 22669917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation.
    Balakrishnan A; Wring SA; Polli JE
    Pharm Res; 2006 Jul; 23(7):1451-9. PubMed ID: 16783481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterobacteria modulate intestinal bile acid transport and homeostasis through apical sodium-dependent bile acid transporter (SLC10A2) expression.
    Miyata M; Yamakawa H; Hamatsu M; Kuribayashi H; Takamatsu Y; Yamazoe Y
    J Pharmacol Exp Ther; 2011 Jan; 336(1):188-96. PubMed ID: 20884752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.